historyOfBreast-conservingSurgery
weak
pcrThanWomenWithHr-positiveTumors
paper
earlyDiagnosis
greater
inception-v3Cnn
limitedPerformanceForWomenWithDenseBreasts
withDevelopmentOfHigh-throughputSequencingHaveDiscoveredInTumorousTissues
fbxo22-dependentManner
tissueMicroarray
therapeuticTargetForPotentialTreatment
125DogSeraSamplesIncluding75MammaryTumourSera
associationStudy
uniqueProperties
multiplexedAssayForDetectionOfAutoantibodiesInCanineTumours
proliferationOfCells
32620MatchedPatientsWithoutPcos
clearEvidenceForbenefitsOfTanUsageInBreastCancerClassification
STs
accomplished
probablyTranscriptionalActivation
markerBands
autopsyStudies
familyImpact
histologicGradeInBreastCancer
neoadjuvantChemotherapyWithHerceptin
phosphorylationOfAkt
conflict
recurrence
6084Years
amount
secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
geneticMutation
tightDoctor-patientCollaboration
sentinelNodeBiopsy
sites
greaterthanorequaltoReduction
mostCommonMalignantTumor
invasiveDiseaseretrospectiveAnalysisOf219Cases
complementaryApproaches
pregnancyOutcomes
subsequentMalignancies
nextMade
comparedToThoseWithPregestationalBreastCancer
assessment
recognized
triple-negativeBreastCancers
expressionLevel
contexts
highestSeInTotalGroup
comparisonToCa15-3
alternativeToFrozenSections
operablePatients
pairedTumor
decreasesInMortalityRates
thanCapecitabineGroup
cssBenefit
despiteTheirRarityShouldConsidered
distinct
associationBetweenRace/colorInWomenWithBreastCancer
them
chosen
inBreastTumorsKnownAsBreastCscs
couldDetectedEarly
addition
evenMorePersonalizedFollow-upSchedules
proliferationOfMcf-7Cells
her2-positiveInvasiveDuctalCarcinoma
healthcareCost
invasiveBreastCancer
detectionOfBreastCancerInWomen
risk/benefitOfDifferentTreatmentModalities
suspected
found
associated
twoGroups
metastaticBreastCancer
properAccessToDiagnosis
scalableIntervention
reducedBaselineLvef
inAdditionFurtherConfirmedInEarlyStage
underutilized
differentPatientRaces
mustAddressed
RL
descriptive
methods
negativelyCorrelatedWithLvef
themVeryDifficult
panelOfCellLinesWithDifferentPhenotypes
collisionTumorWithBreastCancerMetastasis
ligand-bindingDomainAllInBreastCancerSamplesFromPatientsPreviouslyTreatedWithEndocrineTherapy
qualityOfLifeOfPatients'Spouses
broadcasted
alsoShaped
spindleCells
treatment
additionallyRevealed
synthesized
caseOf68-year-oldCaucasianFemaleWithFamilyHistoryOfCancer
hormoneReceptor-positiveTumors
2012AtBreastClinicOfPortugueseInstituteOfOncologyInPorto
vap-1Staining
utilization
childbearingReasonsIncluding
inMultivariateModelsRelatedToPerformanceStatus
chemotherapyResistance
need
henceMajorResearchGoal
breastCancers
vitalRole
atrophiedVaginalMucosa
tumorigenesisOfBreastCancer
30DoublingTimesNecessary
cancer-relatedDeath
canEffectivelyTreatedByEndocrineTherapy
treatmentOfBreastCancer
riskFactorForLung/bronchusCancer
mostFrequentlyOccurringCancer
effectivenessOfNationalScreeningProgrammes
905Percecnt
timeOfTheirAppointmentwithDoctor
prognosticMeritOfNek6ExpressionInBreastCancer
breastTumor
severalObjectives
goal-setting
sparseCombinationOfRiemannianDictionaryAtoms
knownHeterogeneousDisease
noted
largelyConsistent
appliedTo70PatientsWithUnilateralRl
anticipated
likelyParaneoplastic
greatPotentialInDiagnosisTherapyOfCancers
30TBreastMagneticResonanceImagingExaminations
associationBetweenNsaidsExposureInFemalePatientsWithAd
developmentOfSubsequentLung/bronchusCancer
personalGoal-setting
subtyped
blood
normalDucts
this
strongContrastWithImagingModalities
estrogen-aloneArmOfWhi
canOnlyDiagnosedOnPresentationOfSymptoms
effectiveDiagnosisOfBreastCancer
9EuropeanCountries
results
riskFactor
systemicChemotherapy
field
commonPlatformForStakeholdersIncludingPolicymakers
bilateralSalpingo-oophorectomy
memorialSloanKettering-integratedMutationProfilingOfActionableCancerTargets
oneRandomlyAssignedToAxillaryDissection
significantAssociationBetweenLevelsOfNek6
qualityEvidence
standardMethod
westernizedCountries
veryComplexDisease
464Percecnt
preclinicalModels
additionalIndicator
disadvantages
retrospectiveObservationalStudyOf264Her2-positiveAdvancedBreastCancer
urgentlyDeveloped
secretion
associationBetweenTumorUptakeInInvasiveDuctalCarcinoma
timeIntervalsFromFirstDetectionToDiagnosis
improvedQualityOfLife
correlation
inCaseReportTypicalOfAdvance
performance
shouldProceede
capacity
importantContributors
riskOfDevelopmentOfGliomas
relationship
outcome
histopathologicallyProvedBreastTumors
mostPrevalentType
oneScreeningProgramme
hasRecentlyProposedAsCrucialRegulatorOfTriple-negativeBreastCancer
Kazakhstan
changesInHealthBehavioursAfterBreastCancerDiagnosis
MortalityRates
howeverMuchLower
992PercecntOfCases
preservationOfBiomarkerExpressionInOldFfpeTumour
firstTimeIn1984
partialPathologicalResponseWithLargeAreasOfTumourRegression
initiationOfPromptTherapy
cellMigration
specificCancerCell-relatedComponents
heterogeneity
thereforeCriticalSignificance
4
high
417Percecnt
zebrafishTumorModel
moreDesirable
outcomeInEr-positive/humanEpidermalGrowthFactorReceptorType2-negativeBreastCancersWithHighHazardRatiosIndependentlyOfOtherMarkers
uptake
876PercecntRespectively
inStudyFusedWithMouseMyelomaCellLineSp2/0InPresence
serious
lymphaticInvasion
theirHealthBehaviours
independentPrognosticPredictor
inStudyDevelopedForHighlyEfficientIsolationOfCtcsFromBreastCancerPatients
mortalityRates
metastasis
randomEffectsModel
breastCancerMolecularSubtypes
increased
hasFocusedOnTumourCellsPrimarily
analyzedBeforeAnd
prognosticFactorIndependentOfOtherClinicalVariables
21Months
onlyWomen
drastic
thatOfMir-511
dnaMethylationDifferencesBetweenTumorBreastTissue
resultCompatibleWithMetastasisToOrbit
GTPase
tendency
uncommon
cellCycleArrestFollowedByMassiveCellDeath
handheldProbeCapable
molecularPathwaysInvolvedInPathogenesisOfProliferation
painlessLumpInBreastAccountingFor688PercecntOfPatients
date
performedInFemaleParticipantsWithBreastCancerFromJune2015ToDecember2017
statisticallySignificantValuesAt4Cells/7MlBlood
haveDescribedInResponseToNeoadjuvantChemotherapyParticularlyInAssociationWithHerceptinTreatment
incompleteExcisionOfMalignantTissues
bilateralBreastLumps
onEsophagogastroduodenoscopyIdentifiedInAntrum
canImportantToDiagnosis
tripleAssessmentFollowed
betterOs
immunocaptureOfMarker
canIncludedInDifferentialDiagnosisOfMasses
indicative
two-thirdsOfBreastCancerCases
breastCancerConfinedWithinMammaryDuctsSurrounded
significantlyCorrelatedWithOverallSurvival
promoterMethylationInCertainTypesOfHumanTumors
Stem-likeCells
considered
2009-13
associationsOfPhysicalActivityInGlobalHealthInBreastCancerSurvivors
importantTumor-promotingCells
report

cruciferousVegetables
occurrenceOfBreastCarcinoma
clinicalSettingOfPreviouslyVagueDiagnosisInImaging
publicHealthChallenge
access
tomography
testingDatasetsCollectedFrom48Patients
rationaleForTamsAsTherapeuticTargetInBreastCancer
electricalDouble-layerCapacitors
excellentRegionalControl
abstractDataOnTheirClinicalCharacteristics
appropriateDiagnosisOfBreastCancer
successOfSymmetricPositiveDefiniteMatrices
RiskProtection
included
leastAbsoluteShrinkage
Herceptin
expectedInverseCorrelationOfSerumDdtsWithBmi
increaseWithNumberOfSprays
excision
neoadjuvantChemotherapy
CXCR4
differenceBetweenClearcellPlatformsForIsolatingCtcs
administrationOfNeoadjuvant
consequencesForSurvival/relapse
accurateViewOfStateOfMetastasesToAxillaryLymphNodes
variousImportantFunctions
genes
screening
moodOfLife
sameRangeAsCasesWithoutWavelength-dependentMeasurementErrors
humanErrors
henceMainlyBased
mastectomies
taiwanLongitudinalHealthInsuranceDatabase2005
affected
obtained
testing
diverseBiologicalProcesses
prognosticSignificanceOfNlrInEarlyStage
retrospectiveStudyOfWomenTreatedWithTrastuzumabForHumanEpidermalGrowthFactorReceptor2BreastCancerAtMayoClinicBetweenJanuary12000
keysToSuccessfulChestWallResectionForLocallyRecurrentBreastCancerAfterMastectomy
contrast
axillaryClearance
medianFollow-upOf9·
adjacentNon-tumorousTissues
betterDiagnosticAccuracyThanFfdm
SRC
tool
1984
theirRelatedMarkersAtDifferentPointsOfChemotherapyRegimensInMetastaticBreastCancer
promising
developmentOfGraphicallyTailoredScreeningTool
mostCommonCancer
505PercecntOfAnalyzedCases
firstFiveFacebookOpenBreastCancerGroupsInYear2016
concentrationsOfVegf-aInComparisonToCa15-3InBreastCancer
attempted
findings
surveillancePopulation-basedData
inConclusionStronglyAssociatedWithNonparticipationInS
inCaseSecondaryToProximalBronchialObstruction
riskForRecurrence
proposed
chronicDebilitatingLifelongComplication
stillDifficult
furthermoreMoreLikely
commonCauseOfMorbidity
SVM
brainMetastasis
pathogenic
haveObserved
utility
feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
unilateralBreastCancer-relatedLymphedema
deep-CNN
alsoAssessed
irregularHyperintenseLesionInT2InLeftParietalRegion
5CmLess
specificCircumstances
93Percecnt
generalBreastCancerPopulation
mda-mb-231Cells
thatInNon-pcrGroup
inexpensive
overnight
differentContrastAgent
levelsOfEralphaProtein
level
patientEducationIdentification/reportingOfSideEffects
images
er-positiveBreastCancer
ductalCarcinoma
chorea
mostCommonAdultCancersInKenya
patientsWithReducedBaselineLvef
CMIA
nf-krab-inducedIncreasedExpressionOfCcnd1
anti-oncogenicRegulationOfMir-34s
symptomaticWomen
1722Comments
likely
thatInMabaGroup
SE
mostCommonCancerOfAdolescentsAgedAccountingFor56PercecntOfInvasiveBreastCancerInWomen
goodDiagnosticPerformance
termsOfClassification
significantlyAssociated
world
us
managementOfTumour-relatedSymptoms
importantForDiagnosis
effects
changesToIntimateIssuesIncludingSexualHealth
includedInStudy
molecularDiagnosisMethodMake
progression-freeSurvival
haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
CTIBL
otherSites
indicatorOfNacEffectiveness
included.When
40Percecnt
subtype-specificPrognosticSignatures
hasProposed
matthewsCorrelationCoefficientOf8038Percecnt
avoidance
flowCytometry
significanceOfTime-trends
elusiveToTargetedTherapies-theTriple-negativeBreastCancer
hazardRatiosWith95PercecntConfidenceIntervals
prevention
township
505Percecnt
embeddingIntoReproducingKernelHilbertSpace
NMA
breastCancerGeneticsInKenya
bronchoalveolarCarcinomaUnrelatedToKnownMetastaticBreastCancer
breastCancerControlEffortsForIdentification
consultations
OS
observed
bayesianNetworkMeta-analysis
ranging
oncogenesEsr1
improvementInClassificationOfMalignantLesions
992Percecnt
properImaging
themselves
42
prevalenceOfobesityOf277Percecnt
significantlyDecreased
moreAdvancedStages
sexualDysfunction
broadDifferentialDiagnosis
effectOfDscam-as1
differentiallyExpressedInBreastCancerCells
descriptive-analyticCross-sectionalType160FemalePatientsWasselected
associationOfPcdh10Methylation
site-specificBindingLeadingToImprovedCancerTreatmentWithMinimalRisksToNormalCells
CNVs
complex
imperative
q12X
23Studies
physicallyActive
breastCancerRisk
previousStudies
population-basedStudies
axillaryLymphNodeOfBreastCancerPatients
potentialBiomarkerForCancerDiagnosisThanMrnaBiomarkers
lowDiagnosticSensitivityForWomenWithDenseBreasts
essential
objectives
trastuzumabInitiation
mammaryMetastasisFromCarcinomaOfOvarianOrigin
theirBeliefsRegardingCancerCausation
childHealth
generalRadiologistAboutSystemicDiseases
drawbacks
variousRadiologicalChangesLeadingToDiagnosticChallenges
diet
thanDcis
proteinS-100
posteriorFossaOfBrain
clinicalCare
characteristicsInsideTumors
glycosylationOfMembraneTypeMr
highlySensitiveNano-biosensor
breastCancerStaging
active
analyzedRetrospectively
uncover
17Years
18.791
iU22
haveProducedInLaboratories
satisfied
17MillionPeopleWorldwide
delivery
2IndependentCohorts
tumorEasily
foundBetweenMolecularSubtypesWithHer2
expressionOfRrm2
moreComorbiditiesThanSPatients
importantCopingResource
120BreastCancerPatients
significantlyReduced
adherenceToEhtAmongBreastCancerPatients
inPresentStudyConductedBetweenMcf-7Tamoxifen-resistantLcc2CellLines
Israel
documented
canEasilyExtended
outcomesOfEstrogenReceptorPositive
theyCanImpactOnQualityOfLifePresent
opticalCoherenceTomographyImages
fluorescenceImaging
minimalRisksToNormalCells
5-yearResultsOfPhase3Isg23-01Trial
protected
shallow-CNN
cancerGenomeAtlas
mustIndividualized
kaplan-meierCurves
increasingNumber
commonEndocrineDisorder
cancerTreatment
relativelyGoodPrognosisWith5YearOverallSurvivalOf88Percecnt
training
data
typicalWoman'sDisease
life
lowCountries
importance
severalOtherGenes
inConclusionMajorHereditaryBreastCancerGenesIrrespectiveOfAgeAtDiagnosisInJapaneseWomen
singleMetastaticSite
trastuzumab
willDifferentRegardingSubtypeAtDiagnosis
expected
increase
patients'Self-monitoring
evidenceForbenefits
betterOutcomeWithGoodNegativePredictiveValue
canDifficult
able
hasAssociated
breastCancerTherapy
understanding
rightMastectomyWithSentinelLymphNodeBiopsy
releaseFromSerumStarvationInMcf-7Cells
boneDensity
novelStrategiesForDiagnosisOfBreastCancerWithHyperglycemia
role
developmentOfPolicies
assessedPreoperatively
mostFrequentCancerInWomenTreatedWithHormonalTherapy
thatOfOtherCountries
v-gCalciumChannelBindingAntibodies
hypothesis
heavySymptomBurden
Ontario
mostInvasiveDisease
notablyDesigned
haveAssociated
haveDeveloped
third-lineTreatmentForAdvancedTriple-negativeBreastCancerthisRetrospectiveStudy
sensitive
performed
impededApoptosis
pregnancyFrom1959To1966
useful
generalHealth
unnecessaryFollow-upVisitsForWomenWithVeryLowRisks
pathogenesisOfBreastCancer
important
Kenya
inConclusionPathogenicFeatureInPrimarySamples
mayNecessary
healthBehaviours
10.1
strongAssociationBetweenRs5743810AgainstRiskInSaudiArabianWomen
misdiagnosis
highestPerformance
13Percecnt
broadUseToPatients
synchrotronRadiation
created
synonymous
prognosticSignificanceOfNeutrophil-to-lymphocyteRatioInPatientsWithBreastCancer
country
calculated
Porto
lymphedemaPatients
logisticregressions
moreoverStronglyRecommended
strongIndependentPrognosticFactor
proactiveManagementOfPsychologicalHealth
type
tamoxifenResistance
firmlyPlaceWithRecentTrendsTowardDecreasedRatesOfRe-excision
patientsWithMetastaticBreastCancer
canCategorizedIntoSubtypesOfLuminalA
youngWomen
improved
95PercecntConfidenceIntervals
13
pathologicEvaluation
forRace/colorVariableEstimatedWithAdjustmentForStatus
variableMolecularMechanismsOfCarcinogenesis
clinicalPractice
twoUncommonCasesOfDelayedBreastCancerRelapses
presented
widespreadInterest
influences
moreSatisfiedWithTheirCosmeticResultsThanThose
radioisotope
preciseToolForTargetedTreatmentOfCancerIncluding
clinico-epidemiologicalFeaturesOfBreastCancer
imagery
canDiagnosed
detectedByImmunohistochemistryInApproximately70PercecntOfInvasiveBreastCancers
onlySubgroupWithProgesteroneReceptor
mostProminentCause
49CedmCasesCollectedFromMayoClinic
vap-1ImmunohistochemicalStaining
fearOfPartnerLoss
particularEmphasisQuantifying
times
FT
lowRiskLesions
fewPercentOfWomen
survivalDifferences
enhancementOfImage
howeverUnderutilized
oestrogenReceptorCofactors
therapeuticAdvantagesParticularlyInCaseOfPremenopausalBreastCancers
stratifyingForAge
breastCancerCellInvasion
roleOfSupportOfferedByVirtualCommunitiesToBreastCancerPatients
values
successfulQuantificationOfCa15-3InSerumSamplesFromCancerPatients
advantages
canIncluded
issuesOfExistingContrastAgents
lossOf020Quality-adjustedLifeYears
differentStages
diagnosisOfCancer
associationBetweenPost-diagnosisLow-doseAspirinUse
retrieved
status
saudiArabianWomen
negativeMargins
increasedRiskOfEndometrialCancer
relation
noninvasive
firstDataOnPre-diagnosisConcentrationsOfSrankl
13PercecntOfDeaths
Japan
evaluation
differentPhotosensitizerForPhotodynamicTherapy
highlyDiverseGroupOfMalignantNeoplasiaWithPoorOutcome
nowAlsoWidelyUsed
obtainedFrom66FemalePatientsWithMAtDifferentTimeIntervalsForEvaluationOfCtcsByFlowCytometry
significantChallenge
breastTumorProgressionIncludingTumorCellGrowth
thriceHigher
documentedAsImportantTumor-promotingAgentForSeveralHumanCarcinomasIncludingBreastCancer
triple-negativeSubtypeMda-mb-231Cells
estimated
incidenceFactors
inverselyCorrelated
tumors
moreRecommended
stageIi
EMH
diindolylmethane
responsible
pre-diagnosticObesity
bilateralTotalMastectomies
prognosesOfYoungMenWithBreastCancer
seValues
tumorGrowth
inTotalMatchedToCasesOnBirthYear
newDesignDouble-layerCapacitors
down-regulated
criticalScientificBaseForPrecisionMedicineInBreastCancer
over-represented
dcisWithMicroinvasion
highlyEffective
variousLimitationsIncludingToxicity
choiceOfChemotherapyInBrca-associatedCancers
brca-associatedCancers
body
62Years
reducedBaselineCardiacFunction
upregulated
intravenousAdministrationOfOsteopontin-750Probe
diagnosisOfGallbladderMetastasis
collectedFromElectronicHealthRecord
goodDiagnosticAbility
multiyearCollaborationLedByUnionForInternationalCancerControl
canTherapeuticTargetForNextGenerationOfSerms
life-threatening
99PercecntAccuracyInTermsOfClassification
amongThemNewlyIdentifiedInStudy
roleOfPdgf-b/pdgfr-betaAxisInRareTypesOfBreastCancers
only20Percecnt
treat
associatedWithBreastCancerRisk
optimalTherapeuticTargetForPatientWithAdvancedBreastCancer
haveBackboneOfSuchEnormousStridesOfAu
ageOfTreatmentMethods
knowledge
function
1Year
nudeMice
proliferation
lesion
intervalBetweenDiagnosis
medianFollow-upOf48Years
coxProportionalHazardModel
correspondingHistologyImage
formulation
adverseEventsExceptDegreeI-iiBleeding
case-controlAssociationStudyForVariantsInCodingRegionsOf11HereditaryBreastCancerGenesIn7051UnselectedBreastCancerPatientsOfJapaneseAncestry
breastCancerWisconsin
choreiformMovements
vital
complication
dealingWithEndocrineResistanceInPatientsWithBreastCancer
clarify
patients
theirQuestionableImpactOnMortalityOnIncidenceOfAdvancedTumors
developed
medicalDiagnosisOfBreastCancer
performanceEvaluation
canImportant
mustIndividualizedWithEmphasisOnOptimalCareOfMother
lungCancerInHuman
13-hDailyOvernightFast
at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
adulthood
importantlyCouldPotentialDiagnosticBiomarkerInEthnicPopulation
differentPhenotypes
malign
accurateDiagnosisOfBreastCancerSubtypes
T2
poor
mostCommonNeoplasms
postoperativeComplications
normalCardiacFunction
analysis
inexpensiveTechnique
driven
1973To2014
cancer
tumorigenesisOfCells
doublingTimeOfOccult
prognosisOfPatientsWithMaleBreastCancerInShanxiProvinceOfChinaFrom2007To2016
68Percecnt
postmenopausalWomenWithDevelopmentOfBreastCancer
3-timeAssessments
potentialMechanismForFoxc1-inducedMetastasis
associatedWithPfsAlthoughAtExtent
her2-positiveA
mostEuropeanCountries
treatedWithIntraperitonealInjectionFor30Days
potential
fiveGroups
deathInWomenWorldwide
breastCancerYoungerThan45Years
visits
dryness
doxUptakeByCs/bio-mof
evolveTowardLessSurgery
agents
probe
tumorNecrosisFactor
analyzed
mir-193b-3pIdentifiedAsRegulator
haveStudiedInTermsOfCrosstalkBetweenEstrogenReceptorAlpha
complexDueToPotentialFoetalRisksInSettingOfMaternalTreatment
resistanceToMultipleTypesOfTreatmentInBreastCancerModels
currentCancerResearch
inTotalDiagnosedUnderAgeOf50
geneExpressionUpregulationInBreastCancer
positiveSln
veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
anastrozole
her2-positiveBreastCancer
likelihood
suutaneousLymphaticChannelsInReal-time
largeCells
widelyUtilized
youngerAge
evidencedByIncreaseInContrastAfterInjection
women
variousCellularProcessesCellCycleRegulation
novelInsightsIntoPotentialMechanismsAssociatedWithBreastCancerPathogenesis
diverse
highAmountOfDox
inMarch2014BroadcastedAsPart
scrutinized
linearRegression
effectOfDdtSpraysOnBreastCancerIncidenceRate
disease
matched
minimumToxicityToNormalCells
interest
unclear
intralaboratoryValidationSet
detected
disseminatedDisease
WHI
evaluatedInVivo
growthOfFbxo22-depletedEr-positiveBreastCancers
threeYearsBeforeAge64Years
breastCancerAged
long-termEstimates
earlyBreastCancer
variousArtifactsIntroducedDuringSlidePreparation
releaseProfile
needForAnalysisOfMetastaticTissuesAtRecurrence
incidentalFinding
reportOnPerformanceOfBayesClassifiersLikeTreeAugmentedNaiveBayes
consistent
higherProportionOfPatientsWithLymphedema
averageOf425±496Ctcs/2Ml
pairedUntreatedPrimaryTumor
immunohistochemicalDetectionOfErPerformedInRoutineClinicalPractice
information
cutaneousManifestationsOfBreastCancer
virtualRecombinedImagesFromLeImages
sideEffectsOfBreastCancerTherapiesIncludingHotFlushes
howeverGreaterforPatientsTreatedInAlmatyCity
tamoxifen-resistanceInErCancerCells
anti-apoptoticEffectsOfEstradiol
stratification
isReplacedWithRadiotherapyInSituations
decreased
72Months
1YearTo5Years
description
0.46
receivedWithoutSurfaceModification
activeNon-participants
HR
riskOfBreastCancerInAdulthood
differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
users
prognosis
case
neonatal
revealed
metastases
amenorrhea
noticeableDrugLoadingCapacity
costs
markedlyUp-regulated
mayUsed
canConsidered
developmentOfLymphedema
approaches
femaleSibling
S+RT
health
improvement
urgentlyAdvanceImplementation
added
treatingMedicalTeam
localTherapyOfBreastCancer
shouldPerformedInAtRisk
patientsWithNeoplasticDisease
healthExpectancyOfItspopulation
influenceOfSleepQualityOnPmInPatientsTreatedWithHt
sleepDisturbances
historyOfBreastCancer
periodOfObservation
mostRelevantKind
protectiveFactor
advancesInBreastCancerDiagnosis
ourExperience
targets
years
kind
forThoseWithNormalLvef93Percecnt
expressionInBreastCancer
dataOfN=
mostFrequentMalignancy
infraredFluorescentImagingInTripleNegativeInVitro
manifold
YS
needForAwarenessOfMimicsOfBoneMetastasis
detectionOfCancer
increasedRiskOfMortality/relapse
recentlyHaveUsedAsBiomarkers
4.71
real-time
qualityOfLife
relationshipBetweenNlr
prospectivelyFollowedFor3YearsSinceDiagnosis
inHumanBreastCancerHasReported
betterPrognosis
alsoUsed
mistaken
surgicalOptionsIncludingPreservationOfNippleAreolaComplex
inheritableBi-objectiveCombinatorialGeneticAlgorithm
electiveCholecystectomyForSymptomaticCholelithiasis
dscam-as1Expression
betterResults
moreEffectiveTreatmentOfLungCancers
lung/bronchusMalignancies
positivelyAssociated
betterUnderstandingOfRisksAssociatedWithM
theirOriginallyTargetedPopulationsOfBreastCancer
survival
secondary
normalSamples
apoptosis
only44Percecnt
better
breastCancerDiagnosis
womenOfReproductiveAge
substantialDiscordancesBetweenPrimaryTumors
whenSuspected
Chi
independent
comparedBetweenPremenopausalGroupsBetweenPcrGroups
bevacizumab-relatedCardiotoxicity
SNVs
aimed
knowledgeOfM
issues
breastCarcinoma
imaging
unusualCaseOfPtosis
earlyCancerDiagnosis
differenceBetweenDifferentBreastCancerSubtypes
resultOfPreviousOrbitalBiopsy
about30Percecnt
willTestedThroughEuropeanMyPersonalBreastScreening
detectedThroughScreeningThroughSigns
hospitalFromJanuary2016ToFebruary2017
heterogeneousPopulationsOfCellsWithHierarchicalOrganizationDrivenByCancerStemCells
R
impact
retrospectiveStudies
tackled
moreRefinedStratificationThanAnatomicStageAlone
rolePlayedByPdgfFamilyMembersInNormalDevelopmentOfBreastTissueDespiteItsPotentPro-lymphangiogenicEffects
diagnosisOfSulinicalPrimaryCarcinomas
diagnosisAccuracy
KDM4B
typeOfCollisionTumor
non-standardLessPromptTreatmentsIrrespectiveOfComorbiditiesWithIncreasedRiskOfMortality/relapse
haveDiscovered
neuralNetworkClassifier
leadingCauseOfDeathAmongGynecologicNeoplasias
furthermoreSignificantlyMoreLikely
keys
ronInternalization
asResultAreUsed
4Categories
C1
preoperativeAssessment
comparedBetween2GroupstheApatinib
mostFrequentlyDiagnosedCancer
cellCycleRegulators
inclined
backgroundParenchymalEnhancement
magneticResonanceImaging
patientsWithLocoregionalInSouthernPortuguese
significantlyHigherBaselineBpeLevelsThanPostmenopausalWomen
reverseTranscriptionQuantitativePolymeraseChainReaction
safety
DPV
12EventsAmong121Patients
tumorNeoangiogenesisSimilarToBreastMagneticResonanceImaging
formulationOfEffectiveManagementPlanForAt-riskWomen
mir-511Expression
shouldCo-managedByCardiologist
visualizedTheranosticsOfTumors
medications
highestIncidenceAmongMalignanciesDiagnosedInWomen
bodyMassIndex
panel
weakToStrongReactivityToOtherCellLines
consequentlyHaveDeveloped
isReplaced
demonstrate
modeled
pH
fusionProteinsWithHaloTag
biopsy
diagnosisOfResponseToTreatment
diagnosed
10-yearBreastCancerSurvival
thenLinkedToTownshipFemaleBreastCancerIncidenceRateIn2000s
independentPrognosticFactorForDfsOfEarlyStageBreastCancer
understudied
shouldElaborated
mass
similarTendencyRelatedWithPrognosticFactors
subsequentCancerCounselingOfFemaleSurvivors
inPresentStudyPerformedFor9Features
mir-193b-3pBindingTo3UntranslatedRegionOfMorc4
increasedRiskOfTherapy-relatedMorbidity
BMI
thusMeaningful
48Years
patients'MedicalRecords
diagnosticAccuracy
resultsOfStudy
understudiedPattern
sensitivityOf786PercecntRespectively
alongsideRoutineMethodEmployedOnTexture
established
riskOfDeath
structureChanges
sometimesMistaken
worseOutcome
neoplasms
potentialImpact
cscMarkers
evenSeveralChemotherapySessions
highDetectionRateOfSentinelLymphNodeComparableWithRiMethod
unknown
radiologicalSignsOfMalignancy
pool
cellProliferation
excellentPerformanceInFieldOfMedicalImagesDiagnosis
poorPrognosis
thereforeCentralTarget
pleuralDiseaseProgression
conventionalBafifty-fivePatientsUndergoingViaMabaForPtmc
excision/lumpectomy
manyResearchers
correspondingCohort
mayDistinctEntity
defectStudies
healthInitiative
moreResearchLight
hasFound
whenonlyAnalyzed
typical
differentFunctionRegions
therapeuticEffectsInBreastCancer
similarSeriousAdverseEvents
malignantProgressionOfBreastCancer
personalGoals
itsPoorPrognosis
mainlyEurope
prognostic
breastCancerCells
treatedWithCapecitabineMonotherapyAsThird-lineTherapy
comparedBetweenMetastaticSlns
inWorkSynthesizedAsSystemForDeliveryOfDoxorubicinInTreatmentOfBreastCancer
patientsWithHumanEpidermalGrowthFactorReceptor2
spouses
practicalImplicationsOfOngoingChemotherapy
percecntRelapsedTissues
utilized
inflammatoryDiseases
CTC
specificSubtype
expressionProfileOfNek6In133BreastCancerSpecimens
itsPerformance
anxiety
chronic
theirExperiencesLivingWithSister
significantlyYoungerAge
interimStageInProgressionFromDcisToInvasiveBreastCancer
differentHistologicalAspects
peripheralBlood
eventHybridizationOfMirna-21Biomarker
NLR
detectionRateOfMutationsHigherThanThatDescribedInLiterature
lastFollow-upTime
groups
thusAimed
90PercecntOfPatientsWithRecurrence
cardiotoxicRisk
0.02
baGroup
followed
significantCausativeGenes
confirmedUnilateralHer2-positiveBreastCancer
inPaperUsed
expression
er-positive/humanEpidermalGrowthFactorReceptorType2-negativeBreastCancers
2-3Years
cytotoxicity
harmToHealthAmongRuralWomenWithIncrementalCost-effectivenessRatio
attention
higherRisksOfTreatmentDelays
tumorSuppressorGene
commonMalignantDisease
approximately75PercecntOfBreastCancers
standardBiomarkerTestingByImmunohistochemistry
proportion
options
NCAM1
alsoAssessedByQrt-pcr
areaOfResidence
bodyWeight
38Months
stsOfDeath/relapse
lymphNodeMetastasisInPatientsWithBreastCancer
needsInPrevention
understand
their
pretermBirth
microfluidicsBiomarkerDetection
highlyPenetrantGenes
rare
cardiacInjury
oneRegion
factors
breastCancerTissueMicroarrayWithAccessToReceptorAnalyses
iraqiWomenWhencomparedToWesternWorld
twoYears
nomogram
fitted
microscopicTestingOfHematoxylin
highlyExpressed
twoLargeBreastCancerDatabases
whenIntegratedWithinCountry/region'sHealthPlan
hereditaryCausesOfChorea
sixteenRegionsOfKazakhstan
preliminaryGroupOfCtibl
replaced
sample
young
correctionMethod
surgery
switched
stillObscure
mostPrevalentMalignancyDiagnosedInPregnancy
tested
breastCancerTissues
desirable
frequentLargeSingleGiantCellsWithNucleiLocatedPredominantlyWithinSupsularSinuses
sufferingFromWoman'sDisease
old
surgicalExcisionWithRadiation
performedFromInceptionToJanuary312018
discussed
qualitativeApproach
independentPrognosticFactor
evidence
suchLowIncidence
mortalityRate
inFluorescenceImaging
assessments
facilitatingRole
Cells
place
quality-of-lifeFactorsForSurvivorsIncludingSexualDysfunction
oncogenes
analyzedtheOperationTime
genesInvolved
expressionOfMir-511InBreastCancer
panelOf25GenesInvolvedInMechanismsOfTargetedTreatmentResistanceIn16PrimaryBreastCancersDevelopedDuringTreatment
0.32
ourPreviousWorkRegardingToPropertiesOfPluronicsWithDifferentPhotosensitizerForPhotodynamicTherapy
firstTime
canineTumours
extensiveMolecular
antibody-basedStrategy
urgent
conducted
isSentinelLymphNodesMetastasesTo1-2Nodes
peakInRecurrenceRisk
harmfulorHarmlessTissues
challengingProblem
510YearsAfterSurgery
different
combination
mood
concernForExistenceOfCancerCellsInGrafts
pcosGroups
noninvasiveImagingTechniqueForBreastCancerDiagnosis
canStarted
significanceLevel
couldConsidered
MSOT
levels
shouldKept
collisionTumor
131Percecnt
haveBackbone
shouldPerformed
3GroupsBasedOnTertiarySolubleSt-2Level
termsOfMechanism
delaysinTreatment
stableBodyWeight
potentialTherapeuticTarget
neededAcrossCareContinuumEspeciallyInLow-resourceSettings
multicenterStudy
small
formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
couldDetected
necessary
oftenWellScrutinisedByPathologistsForEvidenceOfMetastaticCarcinomaAsImportantPrognosticParameterInStandardSetting
malignantPleuralEffusion
carcinogenesis
phForHer2AgainstHer2-overexpressedBreastCancer
experimentalStudyOfCryo-stabilityOfCancerCells
advancedDiagnosticImaging
earlyStage
tests
MORC4
trastuzumabTherapy
twoCasesOfMimicsOfBoneMetastasis
fibroadenoma
radiation
development
follow-upSchemes
increasedMalignantPotential
S
additionalLocalControl
divided
thereforeApplied
insufficient
adherenceToRecommendationWith95PercecntConfidenceIntervals
team
secondSurgery
.014
femalePatientsWithAd
11BreastRadiologists
inStudyDevelopedByCell-selex
diagnosisOfPatientsWithBreastCancer
theirCare
understood
0.001
currentUsersOfLongerDuration
assessedinclusionCriteriaForEnrolment
histopathologicalExamination
breastCancerScreening
CTCs
195Years
effective
management
pathologyForFurtherFollow-up
differentmethodsOfSelf-treatment
canClassified
events
Barshi
FFDM
specialType
percent
roleOfImage-basedTextureFeaturesAsNoninvasivePrognosticBiomarkers
canUsed
limitations
retrospective
infiltrativeLesion
awareness
represented
firstSymptom
researchers
secondDecadeAfterDiagnosis
outcomes
atEndOfFollow-upClassifiedRegardingTheirAdherenceToRecommendationsForCancerPrevention
moreAdvancedStagingAtDiagnosisInWomen
howeverHaveClarified
oftenHypomethylated
greatClinicalImpactForTumorDiagnosis
higherRatesOfMisdiagnosisForBreastCancer
PI3K/AKT/mTOR
2=
westernBlot
denseBreasts
fieldOfMedicalImagesDiagnosis
scalable
staging
familyHistoryOfDisease
oftenRelated
needed
third
cause
faSignalingNetwork
fewerInstancesOfSpreadToLungs
control
lessLikely
oestrogenReceptorPositiveIn58PercecntOfCasesPositiveIn62Percecnt
stillSeriousHealthProblemIn21stCenturySubjectToManyResearch
present
HER2
biomarkers
glycosylation
potentialTreatmentStrategyForEndocrine-resistantBreastCancers
resources
significantAssociationBetweenRs5743810AllelicFrequency
promisingShort-termStrategiesPriorToTreatmentAdministration
withBetterDrugDeliveryPotentialOfNon-sphericalShapesHaveRecentlyInvestigated
pb-ctMode
secretionOfTumorNecrosisFactor
offered
detectionOfMicrocalcificationInMammograms
imagingModalities
ourExperienceOfHigh-doseRadiotherapy
youngerBreastCancerSurvivors
heterogeneousDiseaseInItsHistologicAppearance
betterOutcomes
rangingFromDiagnosisPhaseToControlOfDisease
duringAgeAssociatedWithIncreaseOf8MoreFemaleBreastCancerCasesPer100000DuringAge50-54
thusCritical
generalPopulation
soFarHasMainlyAssociatedWithMutationsInBrca1
postmenopausalwomen
ca15-3ByCmia
indicator
cancerCells
area
willUsedAsReferences
southernPortuguese
meanwhileBetterThanInCapecitabineGroup
moreLikely
dyspareunia
fourTypesOfBreastCancer
hasApplied
ronReceptorTyrosineKinase
increasedRisk
organotropic
presence
usuallyAssociated
confirmed
linked
positivelyCorrelated
0.007
risk
thenClassifiedBySupportVectorMachines
made
antibodyDrugConjugates
RRM2
increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
alteredInHumanBreastCarcinoma
related
89FfdmCases
7051UnselectedBreastCancerPatientsOfJapaneseAncestry
descriptiveStudy
oedema
stat1RecruitmentToEralphaPromoterRegion
patientsWithMeasurementErrors
interval
0.029
higher
stable
employed
therapy
standardizedDataCollection
type160Patients
MP
tnmStage
breastTumorMicroenvironment
PFS
identified
good
blackWomen
relatedResearchDataOfDiagnosisOfInoperableLocallyAdvancedBreastCancer
mayGoodChoiceForUnilateralPtmc
symptomBurden
aspects
positiveRegulatoryFeedbackLoopForFxyd3Amplification
elusive
healthCareSector
whereFacilitatedBySurfaceModificationOfNps
public
barrierFunction
hasSuggested
AUC
respectivelyFound
undiagnosed
involved
maintenanceOfErCancerStemCells
panelOfMonoclonalAntibodiesAgainstNewlyEstablishedCellLine
pureDcisInClinicopathologicCharacteristics
questionnaireBasedOnAnderson'SdelayModel
progressionOfTumorInvasionInBreastCarcinoma
haMoietyForPdt
effect
willUsed
cancer-relatedEventsIncludingTumorCellMigration
importantInsightsIntoDiagnosisOfPatientsWithDisease
future
Anemia
5Of10Patients
876Percecnt
age
diagnosisOfBreastCancer
ultrasound
therebyFrequentlyNeglected
designed
changes
773Percecnt
clinicalBreastCancerTrials
pcdh10GenePromoterMethylationIdentifiedInDuctalCarcinoma
consensus-based
mistakenDiagnosisOfMalignancy
976PercecntSensitivity
dramaticallyIncreasedAmount
trastuzumabTherapyForBreastCancer
G
solidTumors
tumorBurden
alcoholConsumption
toEndDevelopedWithDrugToAntibodyRatioOf329
lungMetastasesFromBreastCancerPresented
promisingTherapeuticTargetForBreastCancer
decreasedGrowth
critical
haveDescribed
formed
thenAdded
missed
variousEnvironments
riskStratification
haveUsed
chemotherapy
patientsWithBreastCancerReceivingWithAnthracyclines
immunohistochemicalTests
potentialTarget
seen
haveReportedMainlyAfterMastectomy
shouldProcessed
assessmentOfImpactOfAdvancesInDiagnosisOfPatientsWithBreastCancer
protectiveFactors
f-boxProtein22
independentlyAssociated
goodQualityEvidence
currentlyInsufficient
x-rayMammography
study
mayIndicativeOfBenignLesion
relationshipBetweenStromalExpressionOfPodoplaninInInvasiveBreastCarcinoma
differentSubtype
required
only1ulOfSerumSample
target
haveReported
shorterIntervalsBetweenD
bindingToBreastCancerCellsInVitro
developmentOfBrainCancers
diagnosisOfBreastCancer
greaterthanorequalto10PercecntReductionInLvef
importantComponent
applied
alreadyWell-established
shanxiProvinceOfChina
significantlyCorrelated
correlationsBetweenOdds
globalHealth
overallLowOfSixCirculatingMirnas
anti-tumorActivity
expressionOfCxcChemokineReceptor-4
quantification
thirdInTermsOfSpecificMortality
signalAmplificationStrategies
followedFromDateOfFirstDiagnosisOfAdToEndOf2013
advantageOfHigh-throughputLuminexTechnique
riskFactorsOfLvi
termsOfKyotoEncyclopediaOfGenes
primaryPurposeOfPeriodicMammogramsInScreeningProgramsIs
SpCM
kaplanMeierCurves
expressionOf6CirculatingMirnasInOperablePatients
robustTechnology
nationwideRegistries
analysisOfLncrnaExpressionProfiles
canines
TAMs
likelihoodOfDetectionOfMicrometastases
extensiveAttentionOfResearchers
existingEvidenceOnPersonalGoal-settingAmongWomenWithBreastCancerDiagnosis
understandingOfEmergingConceptsOfTumorBiology
malignancy
associationOfToll-likeReceptor6WithBreastCancerInSaudiArabianWomen
hasMadeInMolecularSubtypingOfBreastCancer
obesity
significantlyHigherPcrRatesThanPatientsWithLuminalTypes
sexualStigmatizationOfM
nirProbe
recentlyDiagnosedBreastCancer
protective
patientsWithHistoryOfBreastSurgery
cancerCounseling
breastCancerPatients
differentiation
february2012InNargisDuttMemorialCancerHospital
estimates
comorbiditiesThanSPatients
tumorGrowthInExperimentalModels
identifiablePcrResults
inConclusionDownregulatedInBreastCancer
crucialRole
hasInconsistent
factor
richSpectralFeaturesOfPhenyboronicAcid-basedNanoprobe
emergingPublicHealthProblemInLowCountries
highVolumeAcademicCenters
initialPresentationOfInvasiveBreastCancer
dissection
similar
exon32OfMammalianTargetOfRapamycin
crucialImpactOnDevelopmentOfBreastCancer
theirOwnParticularity
targetRelationshipBetweenDscam-as1
vitalRoles
patterns
developmentOfNewDrugs
needForNodalRadiotherapyInSpecificSituations
90Percecnt
potentialImpactOnFertilityAfterTreatment
breastTumorProgression
patientSelectionForNon-pcosReferenceCohort
possibleCorrelationsWithClinicalStatusIncludingAge
kernelApproach
totalHemoglobinConcentration
whole-tumorSamplingOfDiseaseBurden
6Months
subsequentPrimaries
sulass
rituximab
investigated
processing
stronglyPositive
.021
miR-204-5p
portugueseWomen
50
correlationCoefficientOnMetabricTrainingSet
boneLoss
method
mainlyPostmenopausalWomen
survivalVariance
product
unmetPsychosocialNeeds
metastaticDisease
highMortalityRateForFemales
cancerCareSystems
breastCancerModels
enhancedPossibility
oftenDebated
itsMinimalSilverIonReleaseProfiles
crucial
patientsWithMAmongThem
characterized
positive
pleurodesis
robust
grafts
time-varyingPost-diagnosisLow-doseAspirinUse
earlyStageDiagnosisOfTumors
fieldOfBreastCancerDetection
WES
cancerDiagnosis
pcrResults
associationBetweenPreviousCervicalCancerScreeningInBreastCancerScreening
difference
centralDenmarkRegion
clinicopathologicalCriteria
association
investigatedOnly
pleurodesisForMalignantPleuralEffusion
adjustedHazardRatio
significant
criticalRole
advantage
importanceOfProactivelyAddressingFertility
MCC
problem
standardMethodForEvaluationOfProposedPrognosticTumourMarkers
reported
thereforeRequired
riskFactorsOfLviByMultivariateAnalysis
phosphorylation
inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
breastCancer
evaluated
base
selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
120Patients
connected
worldwide
differentBreastCancerMolecularSubtypes
willLeadToMortalityReductionsWithoutUsualScreeningHarms
real-worldSetting
pCR
shaped
threeCtcsIsolatedFromOnePatient
clinicalVisits
issuesRelatedToTherapeuticSequencingInLocalTherapyOfBreastCancer
itInvolvesInManyCrucialMetabolicProcesses
correlated
women'sCancerAccounting
cutoffValues
thematicAnalysis
defined
single-cellWhole-exomeSequencing
canHeavilyInfluenced
treatmentTherapy
howeverWidelyUnderstood
canExtended
debated
significantlyCorrelatedWithTumorSize
acuteDangerToMother
clinicalVariablesAmongDifferentGroups
humanLife
currentResults
consistentMass-spectralData
alive
balb/cNudeMiceBearing
67BreastCancerSamplesFrom66Patients
potentialTreatmentStrategy
spectrum
fused
major
potentialMechanism
whereDeveloped
cnvsOfDifferentCancers
detectionRate
hypomethylated
sideEffects
invasiveCarcinomaBreast
expressed
localExcision/lumpectomy
explored
fanconiAnemia
ribonucleotideReductaseM2
those
hasAlreadyAssociatedWithDifferentCancersNon-hodgkin'sLymphoma
support
dissectionOfLymphNodes
mostLikelyParaneoplastic
cells
mayUsedForTumourShrinkagePriorToSurgery
course
invasiveDuctalCarcinoma
heterogeneousCancerInFemalePatientsWorldwide
PM
theirRisk
moreEasilyHypomethylated
massInPosteriorFossaOfBrain
moreInformationAboutFurtherStratificationOfBreastCancerSubtypes
DDE
thusWouldCrucialForApplicationOfPreventiveStrategies
trend
key
decreasedRiskOfBreastCancerInFemaleAdPatients
moreAggressiveBiologicalNatureThanPureDcis
closelyAssociated
radiomicsScore
openBiopsyOfNodularityAttachedToPectoralMuscleFascia
estrogenReceptor
itsDiagnosticPerformance
platform
regression
risksOfLate-stageDiagnosis
womenWithMore70PercecntOfPatientsTreatedWithHormonalTherapy
group
multivariateModelsAdjustedForIncome
scrutinised
high-resolutionImages
lowerInEasternThanNorthern/centralEurope
11Days
achievedForHer2Status
capecitabineRegimenAsThird-lineTreatmentForAdvancedTriple-negativeBreastCancer
shouldCo-managed
betterAccessToAtertiaryCancerCenter
copyright
mrnaExpressionLevelOfPcdh10
breastCancerControlEfforts
variablesPredictiveOfNippleAreolaComplexInvolvementInPatients
accessToReceptorAnalysesInCytosolAtDiagnosis
widelyExpressed
locoregionalDiseaseOfUnspecifiedLocation
discrete-timePartiallyObservableMarkovDecisionProcess
metastasisFromLobularBreastCarcinoma
hasPutOnIntrinsicSubtypingBasedInPresenceOfClassicalImmunohistochemistry
closedLoopStructure
foxc1-knockdownBt549Cells
bareCapillaries
timeInMostCountries
threeDifferentUsMachines
0.003
timingOfChemotherapyForBreastCancersWithDifferentMolecularBackgrounds
effectOfBaicalinInBreastCancer
845Percecnt
ctcsFromPeripheralBlood
completionOfReproductivePlans
50PercecntRelapsedTissues
period
byDevelopmentOfHybridomaTechnologyHaveProducedInManyLaboratories
recommended
therapy-relatedConditionsDuringBreastCancerSurvivorship
aspirinUse
cross-sectionalCategories
arms
result
PCOS
revisionsOfAjccBreastCancerStagingSystem
howeverMoreDrastic
associationBetweenPost-diagnosisUseOfLow-doseAspirin
used
evenLessFrequentComplication
tumorSuppressorFunctionOfP53InPathogenesisOfBreastCancer
urgentClinicalProblem
procedure
clinicalCharacteristicsOfCareOfBreastCancerPatients
4Domains
inPrimaryBreastCancerTumorsExpressedDuringNeoplasticTransformation
finding
breastCancerPatientsWithParticularReferenceToOverallSurvivalAndrecurrenceFreeSurvivalAmongBreastCancerPatients
determined
reverseActiveLearningForClassificationOfHealthyBreastTissue
0.520
human
interventionArm
twoCases
cytotoxicityOfFreeDoxMolecules
associationsOfFactorsWithLocoregionalAtDiagnosis
intravoxelIncoherentMotionParameters
carcinoma
M
determine
firstPatientsWithPathologicallyTumor-freeNodes
fastDayBefore
given
Fbxo22
accuracy
novelTherapeuticTargetsFor
baselineBpeLevels
couldPotentialBiomarker
diagnosisOfAcuteCoronarySyndromes
clinicalBreastExaminationCoupledAsPrimaryTool
howeverSwitched
643PercecntWithSignificantDifferenceBetweenWhites
importanceOfNondestructiveTestingInDefectStudies
5Μl
tumor-1
multimodalityTreatmentStrategy
invasiveBreastCarcinoma
estrogen-receptorAmongOtherMarkers
signatures
follow-up
down-regulatedInTissues
practitionerDecisionmaking
automatedAnalysisOfClinicallyRelevantHistopathologicFeature
China
treatments
pathologicallyTumor-freeNodes
non-nsaidUsers
one-waySensitivityAnalyses
imagingInvestigations
otherSubtypesOfBreastCancer
tumorImaging
infraredFluorescentDye
patientsOnAromataseInhibitors
secondLeadingCause
bestStandardTreatmentRegimenAvailable
mostEffectiveTechniqueused
significantlyYounger
inconsistentResults
veryRareCaseOfTraumaticBreastNeuroma
rrm2Expression
effectsOfPcosOnRisksOfGynecologicCancer
significantlyUp-regulated
canCategorized
inBelgiumMostFrequentWomen'sCancerAccountingForTo353PercecntOfCases
alarm
couldIndependentPrognosticBiomarkerForMPatients'Outcomes
worldwideHighestAge-standardizedBreastCancerIncidence
mostCommonCancerInWomen
mustAddressedDuringCancerGeneticCounselingConsultations
withandControllingForTreatmentDelays
asInCaseShouldAlwaysKeptInMindSpeciallyInHighVolumeCenters
suggested
casesWithoutMetastasisOnDiagnosticImaging
preclinicalPhase
breast
patientsByTrastuzumab-pretreatment
queried
improvedDiagnosis
tissueStorageTime
properties
pregnancy
moreInclined
consensus
patternsOfAssociationResults
functions
planning
reference
modified
humanBody
patientsWithHer-2PositiveExpression
system
kaplan-meierRegressionMethods
preoperativeCytologicalDiagnosisOfBreastCancerMetastasesInRegionalLymphNodesIn84Patients
hasMade
youngWomenWithInvasiveLobularCarcinoma
preventionOfDiagnosedBreastCancerInEstrogen-aloneArmOfWhi
pureDcis
breastCancerIncidence
dependentOnRigorousPathologicEvaluationOnAdministrationOfTreatmentDictatedByTumorBiology
20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
ourStudy
higherProportion
hasFocused
resistant
impairedBaselineCardiacFunctionExperience
whenActiveUse
breastCancerPatientsSerum
non-ideal
following
51Days
haveReportedInOnly003-06PercecntOfBreastCancers
inCanadaOfferedInOrganizedPrograms
achieved
byWhichObservedInNondestructiveWayThroughThermalAnalysis
only35CasesOfTraumaticBreastNeuromas
observations
womenWorldwide
medicalHistory
grade
bone-modulatingAgents
cellInvasion
tumourSpread
youngMexicanWomen
inNearFutureContribute
time
foundInPcosCohortThanInComparisonCohort
5-khzFrequencies
uncouplingOfInverseCorrelationBetweenBmi
negativeEffects
profile
algorithm
metastasectomy
survivalThanAdjuvantTherapy
bt549Cells
popular
activatedComplex
neonatalOfRetrospectiveCohortOfPregnantWomenWith
illiterate
aberrantlyExpressed
cell-killingEffectInTriple-negativeSubtypeMda-mb-231Cells
feasible
leftParietalRegion
0.0001
younger
mean
differentDetectionRatesInBreastCancerPatients
perturbation
disposition
value
veryHeterogeneousDisease
regulationOfNras
painless
gtpaseInBreastCancerCells
quality
recognizedAsCtcIn1Of15HealthyBloodSamples
endocrineTherapyResistance
clinicians
theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
model
73-yearOldWomanPresentingWithLeftBreastLumpClinicallyIndeterminate
invasion
developmentOfBreastCancer
urgentlyNeeded
sixGlycosylationSites
ICER
howeverNon-ideal
number
known
earlyBiomarkersOfBreastCancerRisk
participantsWithBreastCancer
efficientSignaturesForClinicalDiagnosis
described
1H
presentedWorkForFeatureExtraction
rapidBreast-cancer-tissueDiagnosis
referral
massSpectrometry
diagnosis
roleOfAutoantibodiesInEarlyCancerDiagnosis
thenPresented
policyActions
her2Status
cancerDeathAmongWomenWorldwide
breastCancerGenes
recentYears
detection
conflictBetweenCareOfMother
relativeThose
malignant
dependent
obtainedFromPatientsWithBreastCancer
penalizedLogisticRegression
244GermlinePathogenicVariants
lessVisits
news
193FemaleParticipants
commonMalignancyWorldwide
howeverElusive
that
context
significantlyProlongedMedianPfs
receiverOperatingCharacteristic
analysed
normalTissues
sensitivity
hereditaryDisease
strong
outcomeInLymphedemaPatients
effectivenessOfDifferentNpatsOnQolInPatientsWithBreastCancer
potentialApplicationForDiagnosisOfCancerInFuture
supportVectorMachine
cnvData
clinicalFeasibilityOfCtcIsolation
414Percecnt
insights
additionallyCorrelated
averageOfFiveInvolvedSites
ourFacility
cancer-relatedDeathsAmongWomen
indispensable
amplifications
group2
proteinExpressionOfNf-krab-p65
731Percecnt
perceptionOfQualityOfCareProvidedByCancerCareNetworkForEarlyDetectionOfBreastCancer
pathologistAnnotation
slnMetastasis
moreIntensiveFollow-up
thereforeAdministered
shouldOvercomeBeforeClinicalApplication
minimal
womenWithBreastCancer
higherRisks
areUsed
univariableLogisticRegressionModels
neoadjuvantSetting
g1/s-phaseCellCycleArrest
unusual
tamoxifen
classified
common
researchLight
womenWithG
loss
microscopicImages
cancerCareNetwork
theirParticularity
shown
postponementVisiting
featuresFromImages
analysisInvestigate
thoughtfulMultidisciplinaryPlanning
thusPotentialTherapeuticTarget
182Percecnt
moreoverPerformedOnMcf-7CellLineInPresenceOfCs/bio-mofCarrier
downregulated
predominant
effectsOfTreatment
potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
usualCare
chapter
immune-mediatedCancer-associatedDisorders
relevant
necessity
bestChancesOfCure
eralphaSignalling
moreTargetedAdjuvantTreatments
screened
moreoverRemarkablyIncreased
average
receiverOperatingCharacteristicCurves
hasReported
643Percecnt
riskFactors
care
diminishedOncospheroid-formingCapacityOfBreastCancerCells
Japanese
earlyBreastCancerSurgery
cancer-relateddeaths
collected
AD
differentiationBetweenBreastCancerInVariousSubtypesOfBreastCancer
assay
clinicalSetting
mostPrevalentMalignancyAmongWomenAroundWorldAreDiagnosedYear
patient
treated
chances
benignBreastLesions
typicalHormone-dependentTumor
manufactured
theirContraceptivePreferences
workflowConsistingOfImmunoaffinityPurification
expressedSeparately
willTested
totalGroup
prohibitivelyExpensive
haveClarified
englishLiterature
challenge
show
neglected
significance
significantlyHigher
evolve
244GermlineVariants
incidenceAmongMalignancies
after6Months'TherapySignificantlyHigherIn3rdTertiaryGroup
initialTreatmentAfterWhich
pre-operativeAssessment
localizedDescriptionOfBreastCancer
features
breastCancerClassification
clinico-pathologicalFeaturesOfMetastases
osteopontinPeptide
newOpportunitiesForDevelopmentOfNovelTherapeuticStrategies
diagnosisOfEstrogenReceptor
pathogenicVariantsInBrca1/2
her2/hrTripleNegativeTnmStages
referenceForClinicians
treatmentMoreAccessibleToBreastCancerPatients
poorAdhesion
contextOfBreastCancer
17MillionPeople
well-established
surveillanceData
overexpressed
littleSurvivalVariance
thereforeHasAppliedToEarlyIdentification
dominantArms
cases
regulated
year
1
including
Development
0.00001
energyImage
m
use
commonMedications
significantIncrease
patientsWithBreastCancer
advancedBreastCancer
locallyAdvancedBreastCancer
gynaecologicalMetastases
moreRecentlyHaveDeveloped
tumor-bearingMiceOfMcf-7BreastCancerCells
howeverKnown
breastCancerSubtypesa
willDifferent
roleOfEstrogens
contrastAfterInjection
mightPromisingTherapeuticStrategyForHormone-therapyRefractoryEr
serumSamplesFromCancerPatients
acid
statisticallyCorrelated
proposedForBreastTumorGrading
compared
LVEF
thusInRecentYearsDemand
available
factorsRelatedToPresenceOfMetastaticDiseaseAtDiagnosis
hasUsed
forefrontOfResearch
252Percecnt
neutralEffects
relativeThoseOfPostmenopausalPatients
possibility
decades
haveReportedForFirstTimeInCaninesInStudy
determinationOfUnderlyingBiologyWithinTumors
malignancies
assessed
poorerPrognosisInWomenWithBreastCancer
opportunities
novelNear-infraredNirFluorescentProbe
couldDetectedByMammographyBySelf-detection
itsHistologicAppearance
examined
initiationOfBreastMalignancy
standardOfCareAsFirst-lineTreatmentOfPatientsWithHer2-positiveAEvenInReal-worldSetting
mostCommonAgentsUsedInBreastCancerTreatment
breastCancerGrading
particular
roleOfPrimaryCaregiver
advancedBreastCancerBearingMutationsInGenesInvolvedInPi3k/ark/mtorSignalingPathway
throughOptimizationTestsChosenAsOptimalConditions
subsequentLung/bronchusMalignancies
multipleBiological
comparison
symptom
danger
megakaryocyteMarker
768PercecntSamplesWithOverexpressionIn76Cases
goodCorrelationBetweenErAnalysedWithCytAtDiagnosisAnalysedWithIhcInArchivedFfpeTissueFromSameTumour
identificationOfDistinctiveGeneticModificationsInDifferentBreastCancerMolecularSubtypes
widelyAcceptedAsStandardOfCareFollowingBreastConservation
oneRegionAnother
roles
autonomyOfPatients
diseaseDefinedByTumor
subsequentlyAssessed
breastCancerScreeningProgramme
injury
standard
annualMammographyAssociatedWithEchography
forefront
breastCancerMcf-7
womenInWorld
mostPervasiveTypeOfCancerAmongWomen
developmentOfEffectiveDrugsForTreatmentOfHormone-dependentBreastCancer
alarmingLevelGlobally
subsequentMalignanciesForLung/bronchusCancerWith13PercecntSurvivorsSufferedFromSubsequentMalignancies
administered
accessToEarlyDiagnosis
mostPowerfulTool
fabricated
inLongTermHasFound
physicalActivityInPatientsWithMetastaticBreastCancer
moreoverPoor
heterogeneous
erCscs
europeanCountries
intratumoralHeterogeneityOfKindOfTumor
positiveChangesInTheirHealthBehaviours
processes
moreDirectional
personalizedFollow-upSchemes
individualRiskOfRecurrence
her2Overexpressing
healthcareUtilization
adherence
thoseWithHr-positiveTumors
comparisonOfPredictedIncidenceOfBreastCancerWithActualIncidenceInPopulation-basedStudies
rates
treatmentStrategy
16PrimaryBreastCancers
importantProblem
pre
mir-193b-3pBinding
furthermoreAssociated
majorCscMarkersDescribedInInvasiveBreastCancer
obscure
BRCA1
heterogeneousDisease
mostCountries
distributions
mutationalStatusBesidesFamilyHistory
importantApplicationProspects
canStartedAtVeryEarlyStage
C
netherlandsCancerRegistryOf37230PatientsWithEarlyBreastCancer
primaryTumor
nslnMetastasis
an
standardOfCareForBreastCancer
melatonin
481Women
hasPut
incidenceFactorsOfSubsequentLung/bronchusPrimaries
humanBiofluid
specificallyPlacedOnInflammatoryBreastCancerWithSkinInvolvementOnCutaneousMetastasesToBreastFromBreastCancer
adjustingForPotentiallyConfoundingFactors
D538G
haveAssociatedWithNippleAreolaComplexInvolvementInPatientsWithBreastCancer
cancerMolecularDiagnosis
areaUnderReceiverOperatingCharacteristicCurve
nano-biosensor
growth
hasWidelyUsed
survivalPrediction
breastMetastasis
immediateUnmetNeedInClinicalPractice
forWomenWithBreastCancerMayMoreFeasible
60ControlPatients
generallyReserved
oneExtraVisit
whenGiven
shouldStaged
based
variables
n-typeVoltage-gatedV-gCalciumChannelBindingAntibodies
potentialImportanceAsModelsForHumanBreastCancer
enrolled
resistance
bulkyHighlyTechnical
methylationStatusOfPcdh10InBreastCancerTissues
binding
differentGeneticProfile
successfulFunctionalizationOfNanocompositeOfSpecificSequenceOfAminatedComplementaryOligonucleotideOfMirna-21
nature
adjuvantAnastrozole
activityOfCellProliferationInBreastCancerCells
identificationOfPredictiveBiomarkersForSelectionOfOptimalTreatment
threeOverallSurvival
large
youngAge
theirPotentialClinicalImplicationsOnBreastCancer
baicalin
protectiveRoleOfRs5743810
realNeedOfSurgicalTreatment
benign
intopreGroups
automaticIntraoperativeIdentificationOfBreastCancerMargins
breastCancerPatientsWith1-2PositiveSlnspatientsWithBreastCancer
activity
consensusOnAssociationBetweenExposureToDdt
controversial
57PercecntOfPatients
patientsWithHer2
only35Cases
westernBlotAnalysis
variousOtherCancerInHumanBody
up-regulated
response
greatPotentialOfClinicalApplication
empiricalTreatmentsBasedOnClinical-pathologicalCharacteristicsToUseOfTargetedApproaches
lower
10Percecnt
er-dependentTranscriptionalActivationViaTransactivationFunction1